Home
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

607 public trials 71 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

NCT01660607

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia, +28 more
Locations: Stanford University School of Medicine Palo Alto, California, United States Palo Alto, California, United States

View Trial Details

Completed

Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation

NCT04621851

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: McGill University - Jewish General Hospital Division of Hematology and Department of Oncology Montreal, Quebec, Canada

Charité University of Berlin - Clinic of Medicine - Hematology and Oncology Berlin, Germany

University of Mannheim, Mannheim, Germania Mannheim, Germany

ASST-Monza Monza, Italy/MB, Italy

View all 26 locations

View Trial Details

Completed

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

NCT02722668

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia/Lymphoma, Acute Myeloid Leukemia, +74 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

INCB018424 in Patients With Advanced Hematologic Malignancies

NCT00674479

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza

NCT01290302

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +23 more
Locations: Luitpold Pharmaceuticals, Inc. Norristown, Pennsylvania, United States

View Trial Details

Completed

Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis

NCT03831776

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Aalborg university hospital Aalborg, Denmark

Aarhus ... Aarhus, Denmark

Copenhagen ... Copenhagen, Denmark

Odense Universitetshospital Odense, Denmark

View all 18 locations

View Trial Details

Completed

TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study

NCT01860456

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Unit of Hematology, Azienda Ospedaliero Universitaria Pisana Pisa, Italy

Division of Hematology and Transplants, University of Siena Siena, Italy

View Trial Details

Completed

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

NCT02988466

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Failure Disorders, +53 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

NCT01350245

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +35 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

TGRX-678 Phase I Oral Pharmacokinetic Study

NCT06697899

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Nanjing Drum Tower Hospital Nanjing, Jiangsu, China

View Trial Details

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Related conditions